首页>投融资

Enveda

C轮

Enveda Biosciences is a biotechnology company engineering new drugs from plants. Its platform applies cutting-edge advancements in knowledge graphs, metabolomics, and machine learning to discover the next generation of small molecule therapeutics.In April 2023, Enveda Biosciences closed an additional $51 million equity financing to add to the $68 million Series B announced in December 2022.In December 2022, the company closed an equity and debt financing of $68-million.In June 2021, Enveda Biosciences announced an oversubscribed $51M Series A funding round

https://envedabio.com/

470178

基本信息

公司全称

Enveda Biosciences
类型

小分子疗法研发商
产业领域

药品研发/制造、医药研发/制造、化学药
公司人数

15~50人
地址

1880 S Flatiron Court,Ste K, BOULDER COLORADO 80301; US; Telephone: +14153235252;
联系电话

+1-415-323-5252
邮箱

info@envedabio.com
成立时间

2019-01-01

投融资

2024-11-22

C轮

1.3亿美元

FPV Ventures

Kinnevik

True Ventures

Dimension Capital

Lux Capital

PremjiInvest

Baillie Gifford
2024-06-14

未透露

5500万美元

PremjiInvest

Lingotto Investment Fund

Microsoft Research

Kinnevik

True Ventures

FPV Ventures

Level Ventures

Jazz Venture
2023-04-20

股权融资

5100万美元

FPV Ventures

True Ventures

Wireframe Ventures

Dimension Capital

Kinnevik
2022-12-21

B轮

6800万美元

Dimension Capital

Allen & Company

Two Sigma Ventures

Hummingbird

Wireframe Ventures

Lux Capital

True Ventures

Possible Ventures

Amino Collective

Level Ventures

Jazz Venture

FPV Ventures
2022-12-21

债权融资

未透露

美国硅谷银行
2021-06-22

A轮

5100万美元

Hummingbird

Catalio Capital Management

Lux Capital

True Ventures

LifeForce Capital

Village Global

Wireframe Ventures

Two Sigma Ventures
2020-10-16

种子轮

490万美元

Village Global

True Ventures

Wireframe Ventures
加载更多

Enveda

基本信息

投融资

相关投融资企业